MediciNova (MNOV) Institutional Ownership $1.34 -0.02 (-1.47%) Closing price 04:00 PM EasternExtended Trading$1.36 +0.02 (+1.42%) As of 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for MediciNova (NASDAQ:MNOV)CurrentInstitutional OwnershipPercentage9.90%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$574.07KNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$288.44K Get MNOV Insider Trade Alerts Want to know when executives and insiders are buying or selling MediciNova stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data MNOV Institutional Buying and Selling by Quarter MediciNova Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bridgeway Capital Management LLC76,031$100K0.0%-24.7%0.000% 8/15/2025 Bank of America Corp DE94,452$124K0.0%-27.3%0.000% 8/8/2025 SBI Securities Co. Ltd.43,479$57K0.0%-22.5%0.089% 2/17/2025 Millennium Management LLC25,923$54K0.0%+26.7%0.053% 2/17/2025 Bridgeway Capital Management LLC122,047$256K0.0%-15.9%0.249% 2/17/2025 Bank of America Corp DE161,312$339K0.0%+111.3%0.329% 2/14/2025 Jane Street Group LLC23,259$49K0.0%+64.5%0.047% 2/14/2025 Schonfeld Strategic Advisors LLC35,751$75K0.0%-13.0%0.073% 2/13/2025 Barclays PLC95,600$201K0.0%+15.5%0.195% 2/12/2025 Geode Capital Management LLC514,914$1.08M0.0%+1.8%1.050% Get the Latest News and Ratings for MNOV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter. 2/6/2025 SBI Securities Co. Ltd.53,771$113K0.0%N/A0.110% 2/4/2025 Y Intercept Hong Kong Ltd36,957$78K0.0%N/A0.075% 11/16/2024 Geode Capital Management LLC505,966$1.06M0.0%+10.3%1.032% 11/15/2024 Jane Street Group LLC14,138$30K0.0%N/A0.029% 11/12/2024 Charles Schwab Investment Management Inc.71,506$150K0.0%-47.0%0.146% 8/9/2024 Renaissance Technologies LLC210,000$302K0.0%-8.9%0.428% 8/9/2024 Dimensional Fund Advisors LP69,372$100K0.0%-35.6%0.141% 2/2/2024 Bank Julius Baer & Co. Ltd Zurich19,000$28K0.0%N/A0.039% 12/6/2023 Citigroup Inc.447,957$936K0.0%-10.1%0.913% 11/9/2023 Citigroup Inc.447,957$936K0.0%-10.1%0.913% 11/7/2023 Barclays PLC103,800$217K0.0%-7.7%0.212% 10/11/2023 Capricorn Fund Managers Ltd30,459$64K0.0%N/A0.062% 8/10/2023 Citigroup Inc.498,257$1.15M0.0%+11.2%1.016% 8/2/2023 Bank of Montreal Can127,300$311K0.0%N/A0.260% 7/20/2023 Bank Julius Baer & Co. Ltd Zurich18,650,237$42.90M0.0%+98,059.1%38.023% 4/18/2023 Capricorn Fund Managers Ltd25,379$55K0.0%-62.0%0.052% 2/10/2023 HRT Financial LP179,202$367K0.0%N/A0.365% 1/17/2023 Capricorn Fund Managers Ltd66,716$137K0.0%N/A0.136% 11/3/2022 Barclays PLC158,300$343K0.0%-12.6%0.323% 7/27/2022 Bailard Inc.17,507$44K0.0%-38.0%0.036% 4/25/2022 Bailard Inc.28,222$75K0.0%N/A0.058% 2/14/2022 Capricorn Fund Managers Ltd53,700$144K0.0%N/A0.109% 2/10/2022 Qube Research & Technologies Ltd13,797$37K0.0%N/A0.028% 2/10/2022 Buckingham Strategic Partners10,000$27K0.0%N/A0.020% 2/1/2022 Qube Research & Technologies Ltd13,797$37K0.0%N/A0.028% 11/15/2021 Marshall Wace LLP284,702$1.08M0.0%-39.8%0.581% 11/12/2021 Renaissance Technologies LLC129,000$489K0.0%-4.5%0.263% 11/12/2021 Geode Capital Management LLC437,781$1.66M0.0%+16.5%0.894% 11/9/2021 Barclays PLC154,016$584K0.0%+52.2%0.315% 11/9/2021BlackRock Inc.1,145,970$4.34M0.0%+1.6%2.340% This stock could leave NVDA in the dust (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here.8/25/2021 Marshall Wace LLP472,956$2.01M0.0%N/A0.966% 8/17/2021 Millennium Management LLC679,803$2.89M0.0%N/A1.394% 8/17/2021 Price T Rowe Associates Inc. MD31,500$134K0.0%-8.9%0.065% 8/17/2021 Boothbay Fund Management LLC18,051$77K0.0%N/A0.037% 8/17/2021 Bridgeway Capital Management LLC102,247$435K0.0%+48.5%0.210% 8/16/2021 Squarepoint Ops LLC28,504$121K0.0%N/A0.058% 8/16/2021 LMR Partners LLP21,783$93K0.0%N/A0.045% 8/16/2021 Cubist Systematic Strategies LLC32,560$138K0.0%N/A0.067% 8/16/2021 Occudo Quantitative Strategies LP19,877$84K0.0%N/A0.041% 8/16/2021 Charles Schwab Investment Management Inc.17,843$76K0.0%-84.0%0.037% 8/16/2021 State Street Corp132,849$565K0.0%-81.0%0.272% 8/16/2021Tibra Equities Europe Ltd84,800$360K0.1%N/A0.174% 8/16/2021 Goldman Sachs Group Inc.82,824$352K0.0%+30.0%0.170% 8/16/2021 Marshall Wace LLP472,956$2.01M0.0%N/A0.970% 8/13/2021 Renaissance Technologies LLC135,100$574K0.0%-14.1%0.277% 8/13/2021 Northern Trust Corp150,697$641K0.0%-70.9%0.309% 8/13/2021 Geode Capital Management LLC375,834$1.60M0.0%-46.4%0.771% 8/13/2021 Vanguard Group Inc.1,826,732$7.76M0.0%-15.7%3.746% 8/12/2021 Dimensional Fund Advisors LP23,470$100K0.0%-13.9%0.048% 8/12/2021 JPMorgan Chase & Co.273,573$1.16M0.0%+7.1%0.561% 8/12/2021Ergoteles LLC177,332$754K0.0%N/A0.364% 8/11/2021 Bank of New York Mellon Corp121,045$515K0.0%-49.7%0.248% 8/11/2021BlackRock Inc.1,127,922$4.79M0.0%-66.7%2.313% 8/10/2021 Principal Financial Group Inc.11,238$48K0.0%N/A0.023% (Data available from 1/1/2016 forward) MNOV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MNOV shares? During the previous two years, 15 institutional investors and hedge funds held shares of MediciNova. The most heavily invested institutionals were Geode Capital Management LLC ($1.08M), Citigroup Inc. ($936K), Renaissance Technologies LLC ($302K), Barclays PLC ($201K), Charles Schwab Investment Management Inc. ($150K), Bank of America Corp DE ($124K), and Bridgeway Capital Management LLC ($100K).Learn more on MediciNova's institutional investors. What percentage of MediciNova's stock is owned by institutional investors? 9.90% of MediciNova's stock is owned by institutional investors. Learn more on MNOV's institutional investor holdings. Which institutional investors have been buying MediciNova's stock? Of the 9 institutional investors that purchased MediciNova's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Bank of America Corp DE ($84.96K), Geode Capital Management LLC ($56.15K), SBI Securities Co. Ltd. ($53.77K), Y Intercept Hong Kong Ltd ($36.96K), Capricorn Fund Managers Ltd ($30.46K), Jane Street Group LLC ($23.26K), and Bank Julius Baer & Co. Ltd Zurich ($19K). How much institutional buying is happening at MediciNova? Institutional investors have bought a total of 273,369 shares in the last 24 months. This purchase volume represents approximately $574.07K in transactions. Which of MediciNova's major shareholders have been selling company stock? The following institutional investors have sold MediciNova stock in the last 24 months: Charles Schwab Investment Management Inc. ($63.29K), Bridgeway Capital Management LLC ($48.10K), Bank of America Corp DE ($35.53K), SBI Securities Co. Ltd. ($12.60K), and Schonfeld Strategic Advisors LLC ($5.35K). How much institutional selling is happening at MediciNova? Institutional investors have sold a total of 164,864 shares in the last 24 months. This volume of shares sold represents approximately $288.44K in transactions. Related Companies IMMP Institutional Ownership TKNO Institutional Ownership SCPH Institutional Ownership ALLO Institutional Ownership SGMT Institutional Ownership SOPH Institutional Ownership AARD Institutional Ownership FENC Institutional Ownership TLSA Institutional Ownership GALT Institutional Ownership This page (NASDAQ:MNOV) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediciNova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediciNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.